Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Appreciative Rheumatology: Positivity Beyond Serologies

Bharat Kumar, MD, MME, FACP, FAAAAI, RhMSUS  |  Issue: April 2023  |  April 7, 2023

Spam, spam, advertisement, spam … wait wait, what’s this? A small envelope, addressed from Maine. I wonder what this is about? Usually, when I get an envelope this size, it’s a letter from someone trying to sell me something or complain about something I have no control over. So imagine my surprise when I found a short letter from Sidney R. Block, DO, referring to a Rheuminations column from the previous month. And it wasn’t hate mail!

The letter read simply, “I enjoyed reading your musings. … One question: Did you ever stop by the farm and ask the person who put up the sign what he or she meant by [Fuel Your Hunger]?”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

I was floored by the physical letter with positive feedback. I couldn’t think of a better way to start the day—the nurses and fellows noted that I had an extra “pep in my step” (a wonderful Midwesternism, might I add). It made me think—rheuminate, if you will—about the need for positive thinking and positive doing. More specifically, this letter led me on a journey to explore Appreciative Inquiry (AI), a framework for translating strengths into meaningful outcomes and strategic plans. The more I read and the more I learned about AI, the more I became a firm believer that what we need in this day and age is Appreciative Rheumatology.

What Is This AI?

When I say AI, chances are that Appreciative Inquiry is not the first thing that comes to mind.1-3 Artificial intelligence, allergy/immunology and autoimmunity typically take precedence. But this AI—Appreciative Inquiry—arguably holds the greatest promise to revolutionize our work environment.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Appreciative Inquiry has been described as a framework, a process or an orientation based on the principles of positive psychology. Developed by David L. Cooperrider, PhD, and Suresh Srivastava, PhD, in 1987, AI was originally applied in the business world to leverage the strength of employees to engage them in positively impacting the organization. The crux of AI is a focus on identifying what works in, and what gives life to, an organization. By focusing on these positive determinants and expanding on those strengths, an organization can grow in a positive manner and render its weaknesses moot.

While AI was originally met with some skepticism, more than 40 years later, evidence exists that AI may indeed improve such outcomes as productivity, engagement, well-being and employee retention. More recently, AI has been applied to healthcare settings, although a recent systematic review did not demonstrate consistent improvement in outcomes in high-quality studies. Nonetheless, AI has enormous potential to improve our work environment and healthcare delivery as a whole.

Page: 1 2 3 4 5 6 | Single Page
Share: 

Filed under:OpinionPatient PerspectivePractice SupportRheuminationsSpeak Out Rheum Tagged with:burnout

Related Articles

    Why Would You Ever Write a Letter of Recommendation or Support?

    April 7, 2023

    I vividly recollect asking my physics professor for a letter of recommendation. I sat in the front row of his lectures and visited his office hours most weeks in the semester. He turned me down because he was “too busy.” I was devastated—and panicked about asking my next choice for letter writer. On the plus…

    Janusian Thinking in Rheumatology

    January 17, 2023

    Happy New Year, readers of The Rheumatologist! As the incoming editor, I want to welcome you back in this new year and hope that you’ll stick around, month after month, as we journey together through 2023. As the year progresses, you may notice some departures from what we have previously done, but I also wish…

    The 2020 ARP Merit Awards & ACR Distinguished Fellows

    December 14, 2020

    During ACR Convergence 2020 in early November, the ACR and ARP honored a group of distinguished individuals who have made significant contributions to rheumatology research, education and patient care. This month, The Rheumatologist speaks with the winners of the ARP Merit Awards and the ACR’s Distinguished Fellows. In addition, we bring you the first ever…

    The ACR Debuts Open Access Journal

    November 19, 2018

    The ACR will add a new professional journal, ACR Open Rheumatology, in January 2019. An open access journal, it will feature the same high-quality, rigorously peer-reviewed articles on original investigations in rheumatology research, as well as commentaries and reviews, as the ACR’s other journals, Arthritis & Rheumatology (A&R) and Arthritis Care & Research (AC&R). Co-Editors-in-Chief…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences